… to malaria control and elimination. Triple artemisinin-based combination therapies (TACTs), …
, might provide effective treatment and delay emergence of antimalarial drug resistance. …

… of an individual drug in clinical trials, the more difficult it is to … in the combination group (group
A), will this regimen be practice-… is shown to be better (or not) than sequential therapy can a …

… were assigned a study number in the sequence of presentation within their … , treatment was
readministered. Children returned the following 2 days to complete their respective regimens. …

… standard regimens showed high success rates against both … : selection bias (random
sequence generation and allocation … out clinical trials or high-quality observational studies that …

… efficacy of these three treatment regimens and the influence of … enrolled in a larger clinical
trial previously published and … ultrasensitive PCR of all consecutive samples of the patients …

… four artemisinin-based combination therapies (4 mg/kg of the artemisinin component, once a
day for three consecutive … A copy of the treatment sheet with dosing regimens is provided as …

… Randomized clinical trials in Asia with dihydroartemisinin-… AL is the only regimen to select
strongly for N86, although this … model simulations, by successive acquisition of the pfkelch13 …

… resulted in high failure rates of artemisinin-based combination therapies (ACTs) in the GMS.
… to malaria control. Triple ACTs (TACTs), combining an artemisinin and two existing partner …

… Appendix 2 for dosing regimens … Therefore, we aim to conduct a large scale randomized
clinical trial in up to 8 … a combination of both study drugs boxes will be sequentially numbered. …

… Artemisinin and artemisinin-based combination therapy (ACT… lumefantrine regimen has been
associated with high treatment … sequentially numbered opaque envelopes kept at each trial …